Form 8-K - Current report:
SEC Accession No. 0000318306-15-000013
Filing Date
2015-05-06
Accepted
2015-05-06 16:29:54
Documents
2
Period of Report
2015-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K r8k-560.htm 8-K 33160
2 PRESS RELEASE DATED MAY 6, 2015 ENTITLED "PLASMATECH BIOPHARMACEUTICALS ANNOUNCE ex_99-1.htm EX-99.1 16105
  Complete submission text file 0000318306-15-000013.txt   50892
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 15837395
SIC: 2834 Pharmaceutical Preparations